Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
EditorialEDITORIALS

Whose Liability Is It Anyway?

M. Donald Blaufox and Alex Gottschalk
Journal of Nuclear Medicine December 2001, 42 (12) 1729;
M. Donald Blaufox
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Gottschalk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

We have served at various times as coeditors, as editors-in-chief, and as authors of numerous books, book chapters, and peer-reviewed articles for several decades. The income from all these activities combined will not contribute significantly to either of our retirements and, in fact, probably not even a good vacation. Most editors and authors do this work primarily because they are academics and teachers, dedicated to education and sharing their knowledge. We are motivated by this goal rather than by financial gain; otherwise we would be in a different business.

Over the years we have dealt with numerous publishers and signed many different forms of author contracts. In recent years we have encountered a clause in some of these documents that has prompted us to write this editorial. Somewhere along the way a lawyer with no evident concept of academia added a paragraph that puts the author at great risk for certain types of legal action taken against the publisher. The contracts ask for the usual attestations that the material used is original and that no other person has a proprietary claim on it. It is certainly reasonable for a publisher to ask that authors certify the originality of their work. The problem comes when the author is asked not only to certify their article’s originality but also to indemnify the publisher against claims to the contrary.

A typical clause may read as follows: “The author warrants that the work is original except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, has not heretofore been published in whole or in part, contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or proprietary right of others.” This is a reasonable statement for the author to be asked to sign. Our concern is the increasing appearance of a clause similar to the following: “The author will indemnify the publisher against any costs, expenses, or damages for which the Publisher may become liable as a result of any breach of this warranty.” This liability exists once the author warrants the originality of his/her work, but now the financial risk is greatly increased.

In the litigious society in which we live, the possibility of such a suit on a frivolous basis is not inconceivable by any means. Yet, it would be ludicrous to even consider matching the assets of the average academic against those of the average publisher. Our assets together could probably be added to the net worth of a publisher without anyone even noticing that there was an increase in value. Even a completely unjustified claim could bankrupt any of us easily. The indemnification puts us greatly at the mercy of the publisher in determining if the warranty has been breached. If the publisher makes this claim the author would need to spend a great deal of money on the legal defense required.

When an article or a chapter is written on some research or medical subject, the publisher usually owns the copyright. Subsequently you cannot even publish your own material without their permission. The bulk of the profits go to the publisher except (in some cases) for a modest royalty, which rarely approaches the expenses of preparing the work. So we are asked to share the expense disproportionately, gain little compensation, and share the legal risk.

These clauses could be construed as legal “boilerplate” in a contract that some of you might run into if you are planning or are writing something to be published. We urge you to look out for such language in the contract. Our practice is to cross out these offending clauses, initial them, and move on. It is interesting that we have never had a publisher refuse to deal with us. It is sort of like the old expression, “If you don’t ask, you won’t get it.” The publishers certainly give it a try; if you refuse them, you still get to publish your work and an unreasonable legal risk is avoided.

Publisher's Note: The Society of Nuclear Medicine does not include a clause, such as the authors describe, to indemnify us as publisher in either our book contracts or in the copyright transfer agreements for journal articles. We encourage all authors to carefully review all copyright transfers and author contracts and to act to protect their interests.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 12
December 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Whose Liability Is It Anyway?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Whose Liability Is It Anyway?
M. Donald Blaufox, Alex Gottschalk
Journal of Nuclear Medicine Dec 2001, 42 (12) 1729;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Whose Liability Is It Anyway?
M. Donald Blaufox, Alex Gottschalk
Journal of Nuclear Medicine Dec 2001, 42 (12) 1729;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feasibility of 177Lu-PSMA Administration as Outpatient Procedure for Prostate Cancer
  • Small Data: A Ubiquitous, Yet Untapped, Resource for Low-Cost Imaging Innovation
  • How to Achieve Approval of Radiolabeled-PSMA Diagnostic and Therapeutic Agents
Show more Editorials

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire